These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36030968)

  • 21. The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.
    Moran-Jones K
    Mol Diagn Ther; 2016 Jun; 20(3):199-212. PubMed ID: 27139908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
    Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
    Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
    Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
    Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
    Fu Z; Taylor S; Modugno F
    Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycle.
    Wright JW; Jurevic L; Stouffer RL
    Hum Reprod; 2011 Jun; 26(6):1408-21. PubMed ID: 21421660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.
    Rodriguez GM; Galpin KJC; Cook DP; Yakubovich E; Maranda V; Macdonald EA; Wilson-Sanchez J; Thomas AL; Burdette JE; Vanderhyden BC
    Cancer Res Commun; 2022 Jun; 2(6):417-433. PubMed ID: 36311166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium.
    Rohr I; Zeillinger R; Heinrich M; Concin N; Vergote I; Nassir M; Mahner S; VAN Nieuwenhuysen E; Trillsch F; Cacsire-Tong D; Chekerov R; Sehouli J; Braicu EI
    Anticancer Res; 2016 Mar; 36(3):1015-22. PubMed ID: 26976992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lipidomic Analyses in Low and Highly Aggressive Ovarian Cancer Cell Lines.
    Zhao Z; Cai Q; Xu Y
    Lipids; 2016 Feb; 51(2):179-87. PubMed ID: 26661829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor.
    Lungchukiet P; Sun Y; Kasiappan R; Quarni W; Nicosia SV; Zhang X; Bai W
    J Steroid Biochem Mol Biol; 2015 Apr; 148():138-47. PubMed ID: 25448740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.
    Li N; Zhao X; Wang L; Zhang S; Cui M; He J
    Tumour Biol; 2016 Jun; 37(6):7767-76. PubMed ID: 26695144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment.
    Kwon Y; Smith BD; Zhou Y; Kaufman MD; Godwin AK
    Oncogene; 2015 Jan; 34(2):144-53. PubMed ID: 24362531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment.
    Wu CJ; Pan KF; Chen JQ; Tao Y-; Liu YC; Chen BR; Hsu C; Wang MY; Sheu BC; Hsiao M; Hua KT; Wei LH
    Oncogene; 2024 Feb; 43(7):511-523. PubMed ID: 38177412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.
    Wu D; Yu X; Wang J; Hui X; Zhang Y; Cai Y; Ren M; Guo M; Zhao F; Dou J
    J Immunol Res; 2019; 2019():9394615. PubMed ID: 31008116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
    Chambers LM; Esakov E; Braley C; AlHilli M; Michener C; Reizes O
    PLoS One; 2020; 15(4):e0228511. PubMed ID: 32348309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.